DiaMedica Therapeutics, Inc. (DMAC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DMAC's 50-day simple moving average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results